Universal Arts (532378)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at a 45% discount to stated book value: P/B of 0.55 against book value of ₹9.02.
• Tiny market cap of ₹5 Cr leaves room for a sharp re-rating if any asset is monetised.
• Positive book value provides some theoretical downside cushion if assets are genuinely worth carrying value.

Concerns

• Latest quarter sales and net profit are both ₹0 Cr, indicating no active earning power.
• Profit growth is -33.33% and sales growth is 0%, with zero dividend yield.
• ROE of 1.65% and ROCE of 3.93% are far below acceptable return-on-capital standards.
• Piotroski F-Score of 3/9 signals weak financial health, and promoter holding is undisclosed.

AI Analysis

At ₹4.93, Universal Arts is priced at only 55% of its ₹9.02 book value. A Graham investor naturally stops to look. But I have to ask: does that book value turn into cash, or is it just inventory and receivables with no earning power? The latest quarter shows sales of ₹0 and net profit of ₹0. Full-year sales growth is 0%, and profits have fallen 33%. The company earns only 1.65% ROE and 3.93% ROCE. That is poor use of capital. A P/E of 42.85 is meaningless when earnings are near zero. There is no dividend, and the Piotroski score is only 3/9. That alone tells me the financial position is weak, and film production is a hit-driven business with no moat I can trust. This is not a wonderful business. It may be a financial cigar butt. The market cap is just ₹5 crore, so any meaningful asset sale or recovery could move the stock. But I do not invest because a stock can bounce. I invest when the math is clear. At 0.55 times book, with no earnings and no visible growth, I would need an independent valuation of the film rights and receivables before treating book value as real. Promoter holding is not disclosed, so I cannot judge alignment. For a value investor, this is a possible asset play, but only after careful digging. I would keep it on the watch list, not on the buy list. As Graham said, price is what you pay, value is what you get. Here, the value is uncertain and the price is low because the business earns little. I will wait for better evidence.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer